We examine how the U.S. Food and Drug Administration Amendments Act (FDAAA) of 2007, which requires additional disclosures regarding clinical trial results, impacts information asymmetry between the disclosing pharmaceutical firm and capital market participants, the general public, academics,...

Against the backdrop of the COVID-19 outbreak, an emergency policy initiative called "Suspending Classes Without Stopping Learning" was launched by the Chinese government to continue teaching activities as schools across the country were closed to contain the virus. However, there is ambiguity...